Review: taking Amitriptyline hydrochloride and Lorazepam together


Summary

Drug interactions are reported among people who take Amitriptyline hydrochloride and Lorazepam together. This review analyzes the effectiveness and drug interactions between Amitriptyline hydrochloride and Lorazepam. It is created by eHealthMe based on reports of 2,570 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Amitriptyline hydrochloride and Lorazepam >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Amitriptyline Hydrochloride

Amitriptyline hydrochloride has active ingredients of amitriptyline hydrochloride. It is often used in depression. (latest outcomes from Amitriptyline hydrochloride 6,837 users)

Lorazepam

Lorazepam has active ingredients of lorazepam. It is often used in stress and anxiety. (latest outcomes from Lorazepam 46,073 users)

On Jul, 21, 2016

2,570 people who take Amitriptyline Hydrochloride, Lorazepam are studied.


Number of reports submitted per year:

Amitriptyline hydrochloride and Lorazepam drug interactions.

Drug effectiveness over time:

Amitriptyline Hydrochloride:
  • < 1 month: 12.0% - (1 of 8 people)
  • 1 - 6 months: 7.0% - (1 of 13 people)
  • 6 - 12 months: 55.0% - (5 of 9 people)
  • 1 - 2 years: 25.0% - (5 of 20 people)
  • 2 - 5 years: 40.0% - (6 of 15 people)
  • 5 - 10 years: 36.0% - (4 of 11 people)
  • 10+ years: 37.0% - (3 of 8 people)
  • not specified: 0.0% - (0 of 0 people)
Lorazepam:
  • < 1 month: 11.0% - (1 of 9 people)
  • 1 - 6 months: 11.0% - (1 of 9 people)
  • 6 - 12 months: 40.0% - (4 of 10 people)
  • 1 - 2 years: 58.0% - (7 of 12 people)
  • 2 - 5 years: 50.0% - (11 of 22 people)
  • 5 - 10 years: 70.0% - (7 of 10 people)
  • 10+ years: 42.0% - (6 of 14 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Amitriptyline Hydrochloride:
  • female: 31.0% - (19 of 61 people)
  • male: 26.0% - (6 of 23 people)
Lorazepam:
  • female: 49.0% - (30 of 61 people)
  • male: 28.0% - (7 of 25 people)

Drug effectiveness by age:

Amitriptyline Hydrochloride:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 75.0% - (3 of 4 people)
  • 30-39: 35.0% - (6 of 17 people)
  • 40-49: 11.0% - (2 of 18 people)
  • 50-59: 35.0% - (10 of 28 people)
  • 60+: 23.0% - (4 of 17 people)
Lorazepam:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 33.0% - (2 of 6 people)
  • 30-39: 58.0% - (10 of 17 people)
  • 40-49: 47.0% - (9 of 19 people)
  • 50-59: 42.0% - (11 of 26 people)
  • 60+: 27.0% - (5 of 18 people)

Most common drug interactions over time *:

< 1 month:
  • syncope
  • loss of consciousness
  • back pain
  • cardiac failure congestive
  • chronic obstructive pulmonary disease
  • coronary arterial stent insertion
  • heart rate irregular
  • heart valve calcification
  • heart valve incompetence
  • labile blood pressure
1 - 6 months:
  • back pain
  • cardiac failure congestive
  • chronic obstructive pulmonary disease
  • coronary arterial stent insertion
  • heart rate irregular
  • heart valve calcification
  • heart valve incompetence
  • labile blood pressure
  • loss of consciousness
  • syncope
6 - 12 months:
  • back pain
  • cardiac failure congestive
  • chronic obstructive pulmonary disease
  • coronary arterial stent insertion
  • heart rate irregular
  • heart valve calcification
  • heart valve incompetence
  • labile blood pressure
  • loss of consciousness
  • syncope
1 - 2 years:
  • cardiac failure congestive
  • chronic obstructive pulmonary disease
  • gastritis
  • cardiac disorder
  • dyspnoea
  • renal failure
  • abdominal pain upper
  • acute pulmonary oedema
  • bronchitis acute
  • candidiasis
2 - 5 years:
  • fall
  • type 2 diabetes mellitus
  • ataxia
  • dysarthria
  • insomnia
  • ventricular extrasystoles
  • depression
  • diabetes mellitus inadequate control
  • diabetic neuropathy
  • dizziness
5 - 10 years:
  • depression
  • obesity
  • nausea and vomiting
  • abdominal pain
  • angina pectoris
  • anxiety
  • arterial occlusive disease
  • arteriosclerosis
  • back disorder
  • bipolar disorder
10+ years:
  • diabetes mellitus
  • migraine - common
  • platelet count increased
  • vertigo
  • anxiety aggravated
  • back disorder
  • bipolar disorder
  • depression
  • diabetic ketoacidosis
  • dizziness
not specified:
  • pain
  • anxiety
  • nausea
  • depression
  • fatigue
  • asthenia
  • pyrexia
  • dyspnoea
  • back pain
  • fall

Most common drug interactions by gender *:

female:
  • pain
  • anxiety
  • nausea
  • fatigue
  • back pain
  • depression
  • asthenia
  • pyrexia
  • headache
  • fall
male:
  • depression
  • anxiety
  • fatigue
  • back pain
  • dyspnoea
  • pyrexia
  • nausea
  • asthenia
  • dizziness
  • fall

Most common drug interactions by age *:

0-1:
  • foetal growth retardation
  • drug exposure during pregnancy
  • maternal drugs affecting foetus
  • anxiety
  • asthma
  • bronchitis
  • convulsion
  • fungal infection
  • psychomotor skills impaired
  • pyrexia
2-9:
  • activated partial thromboplastin time abnormal
  • agitation
  • choking
  • depressed level of consciousness
  • disseminated intravascular coagulation
  • drug maladministration
  • dry skin
  • fibrin d dimer increased
  • grand mal epilepsy
  • haematemesis
10-19:
  • vomiting
  • hydrocephalus
  • pruritus
  • blood creatinine increased
  • cardiac failure
  • constipation
  • dehydration
  • disseminated tuberculosis
  • granuloma
  • hypertension
20-29:
  • vomiting
  • anxiety
  • pyrexia
  • nausea
  • suicidal ideation
  • depression
  • dizziness
  • headache
  • diarrhoea
  • insomnia
30-39:
  • anxiety
  • fatigue
  • dyspnoea
  • depression
  • asthenia
  • hypoaesthesia
  • pain
  • headache
  • suicidal ideation
  • vomiting
40-49:
  • back pain
  • fatigue
  • chest pain
  • dyspnoea
  • constipation
  • pain
  • asthenia
  • depression
  • dizziness
  • pyrexia
50-59:
  • nausea
  • pain
  • anxiety
  • anaemia
  • bone disorder
  • depression
  • fall
  • pyrexia
  • headache
  • fatigue
60+:
  • back pain
  • chronic obstructive pulmonary disease
  • pain
  • cardiac failure congestive
  • syncope
  • fall
  • loss of consciousness
  • dyspnoea
  • asthenia
  • coronary arterial stent insertion

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Amitriptyline hydrochloride and Lorazepam?

Can you answer these questions?

More questions for: Amitriptyline hydrochloride, Lorazepam

You may be interested in these reviews

More reviews for: Amitriptyline hydrochloride, Lorazepam

On eHealthMe, Amitriptyline hydrochloride (amitriptyline hydrochloride) is often used to treat depression. Lorazepam (lorazepam) is often used to treat stress and anxiety. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.